CoChat
Sign Up
Cited by 49

The DOI matches its Crossref record.

Phase I/II Clinical Evaluation of StrataGraft: A Consistent, Pathogen-Free Human Skin Substitute

Schurr, Michael J., Foster, Kevin N., Centanni, John M., Comer, Allen R., Wicks, April, Gibson, Angela L., Thomas-Virnig, Christina L., Schlosser, Sandy J., Faucher, Lee D., Lokuta, Mary A., Allen-Hoffmann, B Lynn·2009·Journal of Trauma: Injury, Infection & Critical Care
DOI 10.1097/ta.0b013e31819849d6PMC PMC2679581
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ta.0b013e31819849d6

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. Batchelor, 1970, HL-A matching in treatment of burned patients with skin allografts., Lancet, 2, 581, 10.1016/S0140-6736(70)90165-0 · DOI
  2. Greenleaf, 1991, Microbial contamination in allografted wound beds in patients with burns., J Burn Care Rehabil, 12, 442, 10.1097/00004630-199109000-00009 · DOI
  3. Mathur, 2008, Microbiological assessment of cadaver skin grafts received in a skin bank., Burns, 35, 104, 10.1016/j.burns.2008.04.001 · DOI
  4. Barnett, 2001, Cadaver donor discards secondary to serology., J Burn Care Rehabil, 22, 124, 10.1097/00004630-200103000-00007 · DOI
  5. MacNeil, 2007, Progress and opportunities for tissue-engineered skin., Nature, 445, 874, 10.1038/nature05664 · DOI
  6. Griffith, 2002, Tissue engineering–current challenges and expanding opportunities., Science, 295, 1009, 10.1126/science.1069210 · DOI
  7. Hrabchak, 2006, Biological skin substitutes for wound cover and closure., Expert Rev Med Devices, 3, 373, 10.1586/17434440.3.3.373 · DOI
  8. Eisenbud, 2004, Skin substitutes and wound healing: current status and challenges., Wounds, 16, 2
  9. Ehrenreich, 2006, Update on tissue-engineered biological dressings., Tissue Eng, 12, 2407, 10.1089/ten.2006.12.2407 · DOI
  10. Supp, 2004, Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes., Burns, 30, 643, 10.1016/j.burns.2004.03.012 · DOI
  11. Harder, 2001, Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic., J Biol Chem, 276, 5707, 10.1074/jbc.M008557200 · DOI
  12. Kisich, 2007, The Constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3., J Invest Dermatol, 127, 2368, 10.1038/sj.jid.5700861 · DOI
  13. Kisich, 2008, Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3., J Allergy Clin Immunol, 122, 62, 10.1016/j.jaci.2008.04.022 · DOI
  14. Pruitt, 1984, Characteristics and uses of biologic dressings and skin substitutes., Arch Surg, 119, 312, 10.1001/archsurg.1984.01390150050013 · DOI
  15. Allen-Hoffmann, 2000, Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS., J Invest Dermatol, 114, 444, 10.1046/j.1523-1747.2000.00869.x · DOI
  16. van der Meulen, 1996, The use of vibratome sections for the ruthenium tetroxide protocol: a key for optimal visualization of epidermal lipid bilayers of the entire human stratum corneum in transmission electron microscopy., J Microsc, 184, 67, 10.1046/j.1365-2818.1996.1070664.x · DOI
  17. Brinkley, 1967, Procedure for embedding in situ selected cells cultured in vitro., J Cell Biol, 35, 279, 10.1083/jcb.35.1.279 · DOI
  18. Steele, 2002, Variable expression of some “housekeeping” genes during human keratinocyte differentiation., Anal Biochem, 307, 341, 10.1016/S0003-2697(02)00045-3 · DOI
  19. Hollox, 2003, Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster., Am J Hum Genet, 73, 591, 10.1086/378157 · DOI
  20. Agerer, 2005, Cellular invasion by Staphylococcus aureus reveals a functional link between focal adhesion kinase and cortactin in integrin-mediated internalisation., J Cell Sci, 118, 2189, 10.1242/jcs.02328 · DOI
  21. Latenser, 2007, National burn repository 2006: a ten-year review., J Burn Care Res, 28, 635, 10.1097/BCR.0B013E31814B25B1 · DOI
  22. Hefton, 1983, Grafting of burn patients with allografts of cultured epidermal cells., Lancet, 2, 428, 10.1016/S0140-6736(83)90392-6 · DOI
  23. Madden, 1986, Grafting of cultured allogeneic epidermis on second- and third-degree burn wounds on 26 patients., J Trauma, 26, 955, 10.1097/00005373-198611000-00001 · DOI
  24. Eldad, 1997, Cryopreserved cadaveric allografts for treatment of unexcised partial thickness flame burns: clinical experience with 12 patients., Burns, 23, 608, 10.1016/S0305-4179(97)00054-5 · DOI
  25. Horch, 2005, Treatment of second degree facial burns with allografts–preliminary results., Burns, 31, 597, 10.1016/j.burns.2005.01.011 · DOI
  26. Rab, 2005, Should dermal scald burns in children be covered with autologous skin grafts or with allogeneic cultivated keratinocytes?–“The Viennese concept.”, Burns, 31, 578, 10.1016/j.burns.2005.01.001 · DOI
  27. Supp, 2002, Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes., J Burn Care Rehabil, 23, 10, 10.1097/00004630-200201000-00004 · DOI · Paper page
  28. Eming, 1998, Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft., Hum Gene Ther, 9, 529, 10.1089/hum.1998.9.4-529 · DOI

Cited by

See all 49

Metadata

Authors
Schurr, M. J., Foster, K. N., Centanni, J. M., Comer, A. R., Wicks, A., Gibson, A. L., Thomas-Virnig, C. L., Schlosser, S. J., Faucher, L. D., Lokuta, M. A., & Allen-Hoffmann, B. L.
Venue
Journal of Trauma: Injury, Infection & Critical Care
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2009-03
Volume
66
Issue
3
Pages
866-874
ISSN
0022-5282
DOI
10.1097/ta.0b013e31819849d6
PMC
PMC2679581
Cited by
49
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phase I/II Clinical Evaluation of StrataGraft: A Consistent, Pathogen-Free Human Skin Substitute. https://app.cochat.ai/papers/10.1097/ta.0b013e31819849d6
The paper
Schurr, M. J., Foster, K. N., Centanni, J. M., Comer, A. R., Wicks, A., Gibson, A. L., Thomas-Virnig, C. L., Schlosser, S. J., Faucher, L. D., Lokuta, M. A., & Allen-Hoffmann, B. L. (2009). Phase I/II Clinical Evaluation of StrataGraft: A Consistent, Pathogen-Free Human Skin Substitute. Journal of Trauma: Injury, Infection & Critical Care. https://doi.org/10.1097/ta.0b013e31819849d6